Join our mailing list!



Official PayPal Seal

(Your shopping cart is empty)

  Home > Diane Publishing Books >

Medicaid Prescription Drugs: CMS Should Implement Revised Upper Federal Limits and Monitor Their Relationship to Retail Pharmacy Acquisitions Costs
Medicaid Prescription Drugs: CMS Should Implement Revised Upper Federal Limits and Monitor Their Relationship to Retail Pharmacy Acquisitions Costs
 
Our Price: $20.00
By John E. Dicken (au)
Year: 2013
Pages: 43
Binding Paperback
ISBN 978-1-4578-5299-2

Product Code: 1457852993

Description
 
States reimburse pharmacies for covered outpatient prescription drugs dispensed to Medicaid beneficiaries. For certain multiple-source outpatient prescription drugs, federal matching funds that states receive to reimburse pharmacies are limited by federal upper limits (FULs). In 2010, the Patient Protection and Affordable Care Act (PPACA)  modified the FUL formula to better reflect pharmacy acquisition costs and thus more effectively control Medicaid expenditures. However, the Centers for Medicare & Medicaid Services (CMS) has not yet implemented the PPACA formula and continues to use FULs that were published in Sept. 2009. CMS currently publishes draft PPACA-based FULs. CMS also recently created the Nat. Average Drug Acquisition Costs (NADACs) for states to consider when setting reimbursement rates. This report (1) describes how CMS develops the NADACs and (2) examines how PPACA-based FULs compare to the NADACs. Tables and figures. This is a print on demand report.

Share your knowledge of this product with other customers... Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
1-800-782-3833
 About Us
 Become an Affiliate
 Privacy Policy
 Send Us Feedback
 
Company Info | Advertising | Product Index | Category Index | Help | Terms of Use
Copyright � 2004 Diane Publishing Company. All Rights Reserved.
Built with Volusion